Loading…
Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant
•The effects of GCs on dynamic and structural properties of EPS were studied.•The tested GCs did not caused detrimental effects on the EPS functionality.•GCs can be incorporated into membrane up to 10wt%.•Surfactant might be a promising strategy for the efficient transport of GCs. Glucocorticoids (G...
Saved in:
Published in: | Respiratory physiology & neurobiology 2018-01, Vol.247, p.80-86 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-c818570d5f1e260e49ffd1347f035a4b9face2313d701d7462babdacea9c44313 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-c818570d5f1e260e49ffd1347f035a4b9face2313d701d7462babdacea9c44313 |
container_end_page | 86 |
container_issue | |
container_start_page | 80 |
container_title | Respiratory physiology & neurobiology |
container_volume | 247 |
creator | Cimato, Alejandra Facorro, Graciela Martínez Sarrasague, Margarita |
description | •The effects of GCs on dynamic and structural properties of EPS were studied.•The tested GCs did not caused detrimental effects on the EPS functionality.•GCs can be incorporated into membrane up to 10wt%.•Surfactant might be a promising strategy for the efficient transport of GCs.
Glucocorticoids (GCs) are used to treat lung disease. GCs incorporated in an exogenous pulmonary surfactant (EPS) could be an alternative management to improve drug delivery avoiding side effects. In the development of these pharmaceutical products, it is important to know the maximum amount of GC that can be incorporated and if increasing quantities of GCs alter EPS biophysical properties. Formulations containing EPS and beclomethasone, budesonide or fluticasone were analyzed (PL 10mg/ml; GC 1–2mg/ml). The microstructure was evaluated by electron paramagnetic resonance spectroscopy, GCs incorporated were determined by UV absorption and polarized light microscopy and surfactant activity with pulsating bubble surfactometer. We found that GCs have a ceiling of incorporation of around 10wt%, and that the GC not incorporated remains as crystals in the aqueous phase without altering the biophysical properties of the surfactant. This fact is important, because the greater the proportion of GC that EPS can carry, the better the efficiency of this pulmonary GC system. |
doi_str_mv | 10.1016/j.resp.2017.09.011 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1945216921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1569904817303105</els_id><sourcerecordid>1945216921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-c818570d5f1e260e49ffd1347f035a4b9face2313d701d7462babdacea9c44313</originalsourceid><addsrcrecordid>eNp9kU1PHSEUhkljo9b6B7poWLqZKWe-Md00aj8SEzd2TRg4XLmZCyMwpv6W_lmZXqs7ExJODs95gfcl5BOwEhh0X7ZlwDiXFYO-ZLxkAO_IMQz9UEAL_CDXbccLzprhiHyIccsyCH19SI6qgXc1G7pj8vcSH3Dys3UbKh3FP36Dzi-Rzsu0806GRxqXYKRK0qViMy3KKx-SVd7qSGWMXlmZrHfn9MoYVIl6Q1-IXDmFLoV_CM0r3SEdrZ_vHqNVcqJz8DNmGuM6uJ6-XveRvDdyinj6vJ-Q39-vbi9-Ftc3P35dfLsuVN12qVADDG3PdGsAq45hw43RUDe9YXUrm5FnOaxqqHXPQPdNV41y1LknuWqa3D8hZ3vd_Jj7BWMSOxsVTpN0mK0QwJu2go5XK1rtURV8jAGNmIPdZZcEMLGGIrZiDUWsoQjGRQ4lD31-1l_GHeqXkf8pZODrHsD8yweLQURlMTunbciWCu3tW_pPDk6jew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1945216921</pqid></control><display><type>article</type><title>Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant</title><source>Elsevier</source><creator>Cimato, Alejandra ; Facorro, Graciela ; Martínez Sarrasague, Margarita</creator><creatorcontrib>Cimato, Alejandra ; Facorro, Graciela ; Martínez Sarrasague, Margarita</creatorcontrib><description>•The effects of GCs on dynamic and structural properties of EPS were studied.•The tested GCs did not caused detrimental effects on the EPS functionality.•GCs can be incorporated into membrane up to 10wt%.•Surfactant might be a promising strategy for the efficient transport of GCs.
Glucocorticoids (GCs) are used to treat lung disease. GCs incorporated in an exogenous pulmonary surfactant (EPS) could be an alternative management to improve drug delivery avoiding side effects. In the development of these pharmaceutical products, it is important to know the maximum amount of GC that can be incorporated and if increasing quantities of GCs alter EPS biophysical properties. Formulations containing EPS and beclomethasone, budesonide or fluticasone were analyzed (PL 10mg/ml; GC 1–2mg/ml). The microstructure was evaluated by electron paramagnetic resonance spectroscopy, GCs incorporated were determined by UV absorption and polarized light microscopy and surfactant activity with pulsating bubble surfactometer. We found that GCs have a ceiling of incorporation of around 10wt%, and that the GC not incorporated remains as crystals in the aqueous phase without altering the biophysical properties of the surfactant. This fact is important, because the greater the proportion of GC that EPS can carry, the better the efficiency of this pulmonary GC system.</description><identifier>ISSN: 1569-9048</identifier><identifier>EISSN: 1878-1519</identifier><identifier>DOI: 10.1016/j.resp.2017.09.011</identifier><identifier>PMID: 28963086</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Beclomethasone ; Beclomethasone - chemistry ; Budesonide ; Budesonide - chemistry ; Cattle ; Electron Spin Resonance Spectroscopy ; ESR ; Exogenous pulmonary surfactant ; Fluticasone ; Fluticasone - chemistry ; Glucocorticoids ; Glucocorticoids - chemistry ; Membranes, Artificial ; Microscopy, Polarization ; Phospholipids - chemistry ; Pulmonary Surfactants - chemistry ; Surface Tension ; Surface-Active Agents - chemistry</subject><ispartof>Respiratory physiology & neurobiology, 2018-01, Vol.247, p.80-86</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-c818570d5f1e260e49ffd1347f035a4b9face2313d701d7462babdacea9c44313</citedby><cites>FETCH-LOGICAL-c356t-c818570d5f1e260e49ffd1347f035a4b9face2313d701d7462babdacea9c44313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28963086$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cimato, Alejandra</creatorcontrib><creatorcontrib>Facorro, Graciela</creatorcontrib><creatorcontrib>Martínez Sarrasague, Margarita</creatorcontrib><title>Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant</title><title>Respiratory physiology & neurobiology</title><addtitle>Respir Physiol Neurobiol</addtitle><description>•The effects of GCs on dynamic and structural properties of EPS were studied.•The tested GCs did not caused detrimental effects on the EPS functionality.•GCs can be incorporated into membrane up to 10wt%.•Surfactant might be a promising strategy for the efficient transport of GCs.
Glucocorticoids (GCs) are used to treat lung disease. GCs incorporated in an exogenous pulmonary surfactant (EPS) could be an alternative management to improve drug delivery avoiding side effects. In the development of these pharmaceutical products, it is important to know the maximum amount of GC that can be incorporated and if increasing quantities of GCs alter EPS biophysical properties. Formulations containing EPS and beclomethasone, budesonide or fluticasone were analyzed (PL 10mg/ml; GC 1–2mg/ml). The microstructure was evaluated by electron paramagnetic resonance spectroscopy, GCs incorporated were determined by UV absorption and polarized light microscopy and surfactant activity with pulsating bubble surfactometer. We found that GCs have a ceiling of incorporation of around 10wt%, and that the GC not incorporated remains as crystals in the aqueous phase without altering the biophysical properties of the surfactant. This fact is important, because the greater the proportion of GC that EPS can carry, the better the efficiency of this pulmonary GC system.</description><subject>Animals</subject><subject>Beclomethasone</subject><subject>Beclomethasone - chemistry</subject><subject>Budesonide</subject><subject>Budesonide - chemistry</subject><subject>Cattle</subject><subject>Electron Spin Resonance Spectroscopy</subject><subject>ESR</subject><subject>Exogenous pulmonary surfactant</subject><subject>Fluticasone</subject><subject>Fluticasone - chemistry</subject><subject>Glucocorticoids</subject><subject>Glucocorticoids - chemistry</subject><subject>Membranes, Artificial</subject><subject>Microscopy, Polarization</subject><subject>Phospholipids - chemistry</subject><subject>Pulmonary Surfactants - chemistry</subject><subject>Surface Tension</subject><subject>Surface-Active Agents - chemistry</subject><issn>1569-9048</issn><issn>1878-1519</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kU1PHSEUhkljo9b6B7poWLqZKWe-Md00aj8SEzd2TRg4XLmZCyMwpv6W_lmZXqs7ExJODs95gfcl5BOwEhh0X7ZlwDiXFYO-ZLxkAO_IMQz9UEAL_CDXbccLzprhiHyIccsyCH19SI6qgXc1G7pj8vcSH3Dys3UbKh3FP36Dzi-Rzsu0806GRxqXYKRK0qViMy3KKx-SVd7qSGWMXlmZrHfn9MoYVIl6Q1-IXDmFLoV_CM0r3SEdrZ_vHqNVcqJz8DNmGuM6uJ6-XveRvDdyinj6vJ-Q39-vbi9-Ftc3P35dfLsuVN12qVADDG3PdGsAq45hw43RUDe9YXUrm5FnOaxqqHXPQPdNV41y1LknuWqa3D8hZ3vd_Jj7BWMSOxsVTpN0mK0QwJu2go5XK1rtURV8jAGNmIPdZZcEMLGGIrZiDUWsoQjGRQ4lD31-1l_GHeqXkf8pZODrHsD8yweLQURlMTunbciWCu3tW_pPDk6jew</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Cimato, Alejandra</creator><creator>Facorro, Graciela</creator><creator>Martínez Sarrasague, Margarita</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201801</creationdate><title>Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant</title><author>Cimato, Alejandra ; Facorro, Graciela ; Martínez Sarrasague, Margarita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-c818570d5f1e260e49ffd1347f035a4b9face2313d701d7462babdacea9c44313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Beclomethasone</topic><topic>Beclomethasone - chemistry</topic><topic>Budesonide</topic><topic>Budesonide - chemistry</topic><topic>Cattle</topic><topic>Electron Spin Resonance Spectroscopy</topic><topic>ESR</topic><topic>Exogenous pulmonary surfactant</topic><topic>Fluticasone</topic><topic>Fluticasone - chemistry</topic><topic>Glucocorticoids</topic><topic>Glucocorticoids - chemistry</topic><topic>Membranes, Artificial</topic><topic>Microscopy, Polarization</topic><topic>Phospholipids - chemistry</topic><topic>Pulmonary Surfactants - chemistry</topic><topic>Surface Tension</topic><topic>Surface-Active Agents - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cimato, Alejandra</creatorcontrib><creatorcontrib>Facorro, Graciela</creatorcontrib><creatorcontrib>Martínez Sarrasague, Margarita</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory physiology & neurobiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cimato, Alejandra</au><au>Facorro, Graciela</au><au>Martínez Sarrasague, Margarita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant</atitle><jtitle>Respiratory physiology & neurobiology</jtitle><addtitle>Respir Physiol Neurobiol</addtitle><date>2018-01</date><risdate>2018</risdate><volume>247</volume><spage>80</spage><epage>86</epage><pages>80-86</pages><issn>1569-9048</issn><eissn>1878-1519</eissn><abstract>•The effects of GCs on dynamic and structural properties of EPS were studied.•The tested GCs did not caused detrimental effects on the EPS functionality.•GCs can be incorporated into membrane up to 10wt%.•Surfactant might be a promising strategy for the efficient transport of GCs.
Glucocorticoids (GCs) are used to treat lung disease. GCs incorporated in an exogenous pulmonary surfactant (EPS) could be an alternative management to improve drug delivery avoiding side effects. In the development of these pharmaceutical products, it is important to know the maximum amount of GC that can be incorporated and if increasing quantities of GCs alter EPS biophysical properties. Formulations containing EPS and beclomethasone, budesonide or fluticasone were analyzed (PL 10mg/ml; GC 1–2mg/ml). The microstructure was evaluated by electron paramagnetic resonance spectroscopy, GCs incorporated were determined by UV absorption and polarized light microscopy and surfactant activity with pulsating bubble surfactometer. We found that GCs have a ceiling of incorporation of around 10wt%, and that the GC not incorporated remains as crystals in the aqueous phase without altering the biophysical properties of the surfactant. This fact is important, because the greater the proportion of GC that EPS can carry, the better the efficiency of this pulmonary GC system.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28963086</pmid><doi>10.1016/j.resp.2017.09.011</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1569-9048 |
ispartof | Respiratory physiology & neurobiology, 2018-01, Vol.247, p.80-86 |
issn | 1569-9048 1878-1519 |
language | eng |
recordid | cdi_proquest_miscellaneous_1945216921 |
source | Elsevier |
subjects | Animals Beclomethasone Beclomethasone - chemistry Budesonide Budesonide - chemistry Cattle Electron Spin Resonance Spectroscopy ESR Exogenous pulmonary surfactant Fluticasone Fluticasone - chemistry Glucocorticoids Glucocorticoids - chemistry Membranes, Artificial Microscopy, Polarization Phospholipids - chemistry Pulmonary Surfactants - chemistry Surface Tension Surface-Active Agents - chemistry |
title | Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T21%3A20%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Developing%20an%20exogenous%20pulmonary%20surfactant-glucocorticoids%20association:%20Effect%20of%20corticoid%20concentration%20on%20the%20biophysical%20properties%20of%20the%20surfactant&rft.jtitle=Respiratory%20physiology%20&%20neurobiology&rft.au=Cimato,%20Alejandra&rft.date=2018-01&rft.volume=247&rft.spage=80&rft.epage=86&rft.pages=80-86&rft.issn=1569-9048&rft.eissn=1878-1519&rft_id=info:doi/10.1016/j.resp.2017.09.011&rft_dat=%3Cproquest_cross%3E1945216921%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-c818570d5f1e260e49ffd1347f035a4b9face2313d701d7462babdacea9c44313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1945216921&rft_id=info:pmid/28963086&rfr_iscdi=true |